COVID-19: Oxford vaccine's late stage trials to start in a week in India, says ICMR
Video Credit: ANI - Duration: 02:24s - Published
COVID-19: Oxford vaccine's late stage trials to start in a week in India, says ICMR
Director General of Indian Council of Medical Research, Dr Balram Bhargava on August 04 stated that Oxford vaccine, being manufactured by Serum Institute of India, got approval for phase 2 and 3 clinical trials which are starting within a week at 17 sites.
Director General of the Indian Council of Medical Research (ICMR), Dr Balram Bhargava said three vaccine candidates are at different clinical trial stages in India. Covid-19 vaccine candidates being manufactured by Cadila Healthcare and Bharat Biotech have completed the first phase of the trial while the Serum Institute of India (SII) will begin with Phase 3 trial after getting the nod, Balram Bhargava, ICMR’s director general, said during the health ministry’s briefing.The Pune-based Serum Institute will conduct the Phase 3 trial on 1,500 volunteers across 14 locations, Bhargava added.
Credit: HT Digital Content Duration: 01:19Published
Director General of Indian Council of Medical Research, Balram Bhargava on September 15 informed about the COVID-19 vaccines trial stage in India. He said, Cadila and Bharat Biotech have completed phase-I trials and Serum Institute has completed phase II-B3 trials, and will start phase-III trials after clearance. He said, "3 vaccines are at clinical trial stage in India. Cadila and Bharat Biotech have completed phase-I trials. Serum Institute has completed phase II-B3 trials, and will start phase-III trial (with 1500 patients at 14 locations) after clearances."
Indian Council of Medical Research, Director General Dr. Balram Bhargava during Health Ministry's briefing on COVID-19 situation in India informed about the sero survey publication. Bhargava said, "ICMR sero survey is publication in-progress. It should appear by this week in the Indian Journal of Medical Research. It has been peer reviewed. The second national sero-survey should be completed in the first week September". On situation of COVID-19 vaccines in India, Balram Bhargava said, "Three COVID-19 vaccines are ahead in the race in India. Serum Institute's vaccine is in phase 2(B) and phase 3 trials and Bharat Biotech and Zydus Cadila's vaccines have completed phase 1 trial."
Indian Council of Medical Research, Director General Balram Bhargava when asked on who is diving the pandemic, said, "Irresponsible, less cautious people who are not wearing masks are driving the pandemic in India." He further reacted on re-infection of one case in Hong Kong. He said, "We have read report on re-infection of one case in Hong Kong. It can depend on several factors. It could be related to the patient's immune status, whether the virus has mutated. We need to closely follow it up, but at the same time we don't need to be alarmed".
Health Secretary Matt Hancock seeks to reassure the public as trials of the Oxford University Covid-19 vaccine have been put on hold owing to a reported side effect in a patient in the UK. Report by Jonesia. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn
The Fantasy Premier League has named a new winner for the 2019/20 season afterthe original was disqualified for a breach of the game’s terms and conditions.Josh Bull, a researcher in mathematical oncology at Oxford University, hasreplaced Bulgarian fantasy football manager Aleksandar Antonov two weeks afterthe end of the season.
Credit: PA - Press Association STUDIO Duration: 01:22Published
The Drugs Controller General of India (DCGI) has given approval to Serum Institute of India (SII), Pune, to conduct Phase II and III clinical trials of Oxford University. According to the World Health Organization (WHO), a number of vaccines are now in phase-3 clinical trials. Meanwhile, Chief Minister of Madhya Pradesh Shivraj Singh Chouhan on August 03 again tested positive for COVID-19 on the 10th day of his admission to hospital. Today, Andhra Pradesh reported 7,822 new COVID-19 cases, taking the total number of coronavirus cases in the state 1,66,586. Uttar Pradesh reported 4,473 new COVID-19 cases and 50 deaths in the last 24 hours, taking active cases to 40,191 and death toll to 1,778. Tamil Nadu reported 5,609 new COVID-19 cases and 109 deaths in the last 24 hours, taking total cases to 2,63,222 including 2,02,283 discharges and 4,241 deaths.
From the CEO of the world's largest vaccine manufacturer commenting on the possible timeline of the final vaccine reaching every person on the planet, to the World Health Organisation warning that the months of October and November 2020 could be 'tougher' - here are the top news updates on the Covid-19 pandemic. Adar Poonawalla, chief executive of Serum Institute of India reportedly said that it might take 4-5 years for the vaccine to reach everyone. He estimated that around 1,500 crore vaccine doses would be required to inoculate everyone if the final vaccine is a 2-dose drug. Meanwhile, the Government of India banned the export of onions after a 30% jump in export of the kitchen staple in the April-July 2020 period. Over a dozen Members of Parliament were found to be Covid positive on the day the central legislative body convened for its monsoon session. In Delhi, the deputy Chief Minister, Manish Sisodia, tested positive on the day that the Chief Minister of neighbouring Haryana, Manohar Lal Khattar, finally recovered from the disease. Watch the full video for the other top updates on the spread of the Sars-CoV-2 coronavirus.
Credit: HT Digital Content Duration: 02:18Published
In the last 24 hours, 12 lakh COVID tests were conducted across the country which is an all-time record high. India's total number of coronavirus tests is more than 6.37 crore so far. Meanwhile, India's COVID-19 case tally crossed 54-lakh mark with a spike of 92,605 new cases and 1,133 deaths in last 24 hours. According to Ministry of Health and Family Welfare, the total case tally stands at 54,00,620 including 10,10,824 active cases, 43,03,044 cured/discharged/migrated and 86,752 deaths. As per Indian Council of Medical Research (ICMR), 6,36,61,060 samples were tested up to 19th Sep, of these, 12,06,806 samples were tested yesterday.
Health Minister of Delhi, Satyendar Jain on September 19 briefed media over the current situation of COVID-19 in national capital. He said, "When people in such large numbers are getting infected in Delhi and other parts of the country, it should've been admitted that there is community spread... but only ICMR or Central govt can comment on this."
Maharashtra Deputy Chief Minister Ajit Pawar reviewed ongoing construction work of Pune Metro on September 17. He is in Pune to attend weekly review meeting on COVID-19 that will be held later today. Deputy CM Pawar was accompanied by Maharashtra government officials.
A Covid-19 patient died at home in Pune after being unable to get a bed in any hospital. The patient from Khanapur village of Pune died on September 11. "He died because he could not get a bed in any hospital. When his health deteriorated, we called the ambulance but to no avail," said Nilesh Javalkar, the village sarpanch. The youth’s body was carried on a handcart for cremation as no vehicles were available. Watch the full video.
Credit: HT Digital Content Duration: 01:43Published
Council of Scientific and Industrial Research on September 20 informed that Drugs Controller General of India has approved CSIR's paper-based testing kit called Feluda for COVID-19. CSIR, Director General S Mande said, "Our Delhi CSIR lab's been working on studying CRISPR-Cas immunity. They have experience of working in this particular area before COVID-19 and could repurpose the thing for COVID and developed a paper-based testing kit called Feluda and got formal approval from DCGA. Mande further explained the functioning of the paper based test. "It's different as RTPCR detects RNA and amplifies it using a polymerase chain reaction that is costly. This paper-based test also detects RNA but by a CRISPR guided system. The paper lights up if there is any virus RNA to show a sample is positive, in 45 minutes," he added.
As clinical trials of different COVID-19 vaccines are in various phases across the globe, an AIIMS (All India Institute of Medical Sciences) doctor said that if everything goes as planned, people can..
As per the data released by Ministry of Health and Family Welfare, India on September 18 reported single-day spike of 96,424 new coronavirus cases in the last 24 hours. 1,174 deaths in the same period,..